To include your compound in the COVID-19 Resource Center, submit it here.

Analyst picks & changes

By BC Staff | Jan 30, 1995 | 8:00 AM GMT

Genentech Inc.

Genzyme Corp.

Piper Jaffray analyst Barbara Hoffman said she is enthusiastic about three cystic fibrosis therapies — Genentech Inc.'s

Pulmozyme

DNase,

Read the full 223 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE